Patents by Inventor Pauline Stanislawski
Pauline Stanislawski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10730999Abstract: The present invention generally relates to macromolecules of dendrimer-drug conjugates. In particular, the invention relates to macromolecules comprising a pharmaceutically active agent, such as a protein or peptide, attached to a core of a dendrimer derived from branched building units, such as lysine or lysine analogues. The invention also relates to the synthesis of the dendrimers and macromolecules, and the use of such macromolecules, particularly in therapeutic applications, and pharmaceutical compositions comprising them.Type: GrantFiled: June 5, 2015Date of Patent: August 4, 2020Assignee: Starpharma Pty LtdInventors: David James Owen, Pauline Stanislawski, Michael Giannis, Oliver Bernhard
-
Publication number: 20170189543Abstract: The present invention generally relates to macromolecules of dendrimer-drug conjugates. In particular, the invention relates to macromolecules comprising a pharmaceutically active agent, such as a protein or peptide, attached to a core of a dendrimer derived from branched building units, such as lysine or lysine analogues. The invention also relates to the synthesis of the dendrimers and macromolecules, and the use of such macromolecules, particularly in therapeutic applications, and pharmaceutical compositions comprising them.Type: ApplicationFiled: June 5, 2015Publication date: July 6, 2017Inventors: David James Owen, Pauline Stanislawski, Michael Giannis, Oliver Bernhard
-
Patent number: 9303026Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: GrantFiled: December 20, 2013Date of Patent: April 5, 2016Assignee: BIOTA SCIENTIFIC MANAGEMENT PTY. LTD.Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Publication number: 20140179709Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: ApplicationFiled: December 20, 2013Publication date: June 26, 2014Applicant: Biota Scientific Management Pty LtdInventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Patent number: 8624025Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: GrantFiled: July 3, 2012Date of Patent: January 7, 2014Assignee: Biota Scientific Management Pty LtdInventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Publication number: 20130005736Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: ApplicationFiled: July 3, 2012Publication date: January 3, 2013Applicant: BIOTA SCIENTIFIC MANAGEMENT PTY LTDInventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Patent number: 8217171Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: GrantFiled: May 4, 2011Date of Patent: July 10, 2012Assignee: Biota Scientific Management Pty. Ltd.Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Publication number: 20110212966Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: ApplicationFiled: May 4, 2011Publication date: September 1, 2011Applicant: BIOTA SCIENTIFIC MANAGEMENT PTY LTDInventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Patent number: 7951955Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: GrantFiled: May 1, 2008Date of Patent: May 31, 2011Assignee: Biota Scientific Management Pty LtdInventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Patent number: 7829705Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: GrantFiled: November 13, 2006Date of Patent: November 9, 2010Assignee: Biota Scientific Management Pty. Ltd.Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Patent number: 7579465Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: GrantFiled: November 13, 2006Date of Patent: August 25, 2009Assignee: Biota Scientific Managment Pty. Ltd.Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Publication number: 20090030000Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: ApplicationFiled: May 1, 2008Publication date: January 29, 2009Applicant: BIOTA SCIENTIFIC MANAGEMENT PTY. LTD.Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Publication number: 20070149531Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: ApplicationFiled: November 13, 2006Publication date: June 28, 2007Applicant: BIOTA SCIENTIFIC MANAGEMENT PTY. LTD.Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Publication number: 20070149530Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.Type: ApplicationFiled: November 13, 2006Publication date: June 28, 2007Applicant: BIOTA SCIENTIFIC MANAGEMENT PTY. LTD.Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Patent number: 7166604Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals as well as novel intermediates useful in the preparation of the compounds of formula IType: GrantFiled: December 18, 2001Date of Patent: January 23, 2007Assignee: Biota Scientific Management Pty LtdInventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
-
Publication number: 20040077633Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals as well as novel intermediates useful in the preparation of the compounds of formula I.Type: ApplicationFiled: October 17, 2003Publication date: April 22, 2004Inventors: Keith Watson, Guy Krippner, Pauline Stanislawski, Darryl McConnell
